ColumviPatient Assistance Program

Introduction

A diagnosis of relapsed or refractory large B-cell lymphoma can be overwhelming, especially for patients who have already undergone multiple rounds of treatment. When lymphoma returns after treatment or stops responding to therapy, finding additional treatment options becomes a critical part of ongoing care. Newer immunotherapy treatments have expanded the options available for some patients facing these challenges.

Columvi is an innovative cancer immunotherapy designed to help the body’s immune system target and destroy certain lymphoma cells. Unlike traditional chemotherapy, Columvi uses a targeted approach that connects immune cells directly to cancer cells, helping activate an immune response against the disease. For eligible patients, this treatment offers another option if previous therapies have not provided adequate disease control.

Because Columvi is a specialty biologic medication administered in specialized treatment settings, the overall cost of therapy can be significant. Many patients and caregivers researching the Columvi patient assistance program are looking for ways to manage treatment expenses while maintaining access to prescribed care.

Prescription Hope offers qualified patients access to the Columvi Patient Assistance Program.

 

What Is the Columvi Patient Assistance Program?

Brand-name medications can often be too expensive for many Americans to afford. To help alleviate this problem, pharmaceutical manufacturers often launch patient assistance programs dedicated to helping patients afford specific brand-name medications.

Each program is designed to help qualified patients access specific brand-name medications at affordable rates.

Unfortunately, these programs can have difficult application processes that leave patients feeling overwhelmed and confused.

 

How Expert Advocates Help Make Columvi More Affordable

Personalized Medication Access Assistance

Prescription Hope helps patients who qualify access their affordable medications through patient assistance programs.

This means we handle the process from start to finish. We complete forms, handle collecting documents, gather signatures, and coordinate with the manufacturer throughout the process.

Ongoing Advocacy and Refill Support

Not only do we manage the application process, but after a patient is approved by their program, we continue to handle refill schedules, document updates, yearly renewals, and more.

Predictable Monthly Pricing

All of our services are included in our simple service rate of $70.00 per month, per medication. That means no surprise charges, confusing pricing systems, or medication costs.

Columvi Patient Assistance Eligibility

General Eligibility Requirements

Those interested in accessing the Columvi Patient Assistance Program through Prescription Hope must meet certain criteria to qualify. Requirements typically fall into several general categories:

Income Threshold: Every patient assistance program maintains its own income threshold requirements.

Residency: All applicants must be valid US residents to qualify.

Prescription: Patients must have a current and valid prescription for the medication they wish to apply for.

Insurance: Each program maintains its own requirements regarding insurance coverage status.

 

Simple Enrollment With Expert Support

Getting Started With Enrollment

If you want to apply for the Columvi Patient Assistance Program through Prescription Hope, then you can enroll in 6 simple steps:

• Submit Information: Complete our online enrollment form in just a few minutes.
• Advocate Contact: Patients can expect to be contacted by our team within 1-2 business days.
• Document Collection: Following prequalification, we get to work collecting all necessary documents.
• Provider Coordination: We contact your healthcare provider to secure needed signatures.
• Program Submission: Our team collects everything and submits your application. We continue to coordinate with the manufacturer throughout the process.
• Medication Delivery: After approval, patients typically receive their medication within 2 weeks. All meds are shipped directly from the manufacturer to their door or doctor’s office.

Prescription Hope does not handle medications at any time.

 

Continued Access Support

Prescription Hope services don’t stop after the initial shipment of medication is received. We continue to help patients with refill scheduling, document updates, yearly renewals, program monitoring, and more.

All for $70.00 per month, per medication.

 

Understanding Columvi

How Columvi Works

Columvi is a targeted immunotherapy that contains the active ingredient glofitamab-gxbm. It belongs to a class of medications known as bispecific monoclonal antibodies. It is specifically designed to help the immune system recognize and attack certain lymphoma cells.

The medication works by binding to two different targets. One part attaches to CD20 proteins on the surface of cancerous B cells. The other part attaches to CD3 proteins on T cells, which are important immune system cells. By connecting these cells together, it helps direct the body’s immune response toward lymphoma cells and supports the destruction of cancerous B cells.

This targeted mechanism differs from traditional chemotherapy because it focuses on activating the immune system against cancer cells rather than directly attacking rapidly dividing cells throughout the body.

 

What Conditions Does Columvi Treat?

Columvi is FDA-approved for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, and large B-cell lymphoma arising from follicular lymphoma after two or more prior lines of systemic therapy.

Relapsed lymphoma occurs when cancer returns after previous treatment, while refractory lymphoma refers to a disease that does not adequately respond to therapy. Patients receiving the medication have typically undergone multiple prior treatments and require additional therapeutic options to help manage their disease.

Healthcare providers may consider Columvi for eligible patients whose lymphoma has progressed despite previous treatment approaches or whose cancer has returned following earlier therapies.

 

Benefits of Treatment

Columvi provides an additional treatment option for adults with relapsed or refractory large B-cell lymphoma who have already received multiple prior therapies. The medication uses the body’s own immune system to help identify and destroy lymphoma cells, offering a targeted treatment approach for difficult-to-treat disease.

Clinical studies demonstrated meaningful response rates in certain patients receiving Columvi after previous treatments were unsuccessful. Another notable feature is its fixed-duration treatment schedule. Unlike some cancer therapies that continue indefinitely, it is administered according to a defined treatment course, which may be appealing for some patients and healthcare providers.

Treatment outcomes vary from person to person, and healthcare providers monitor effectiveness through imaging studies, laboratory testing, physical assessments, and ongoing evaluation throughout treatment.

 

Important Safety Information and Side Effects

Columvi carries an FDA Boxed Warning for Cytokine Release Syndrome (CRS), a potentially serious and sometimes life-threatening immune response that can occur during treatment. Symptoms may include fever, chills, low blood pressure, rapid heartbeat, breathing difficulties, and confusion. To help reduce this risk, patients receive a step-up dosing schedule, premedications, and close monitoring during treatment.

Common side effects reported with Columvi include cytokine release syndrome, fatigue, fever, rash, diarrhea, musculoskeletal pain, infections, neutropenia, low white blood cell counts, and low platelet counts. Many of these side effects are related to the medication’s immune system activity.

It can also cause serious neurologic toxicities, including Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS). Patients should immediately report symptoms such as confusion, speech difficulties, tremors, dizziness, altered consciousness, impaired attention, or seizures.

Serious infections may occur during treatment, including bacterial, viral, fungal, and opportunistic infections. Healthcare providers monitor patients closely for signs of infection before and during therapy. Hepatitis B virus reactivation can also occur, which is why screening is recommended before treatment begins.

Additional serious risks include tumor flare, tumor lysis syndrome, anemia, thrombocytopenia, and neutropenia. Routine blood testing and clinical monitoring are important throughout treatment to help identify and manage potential complications.

Columvi may cause fetal harm if used during pregnancy. Females who can become pregnant should use effective contraception during treatment and for one month after the final dose. Patients who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before starting therapy.

Because treatment is highly specialized, patients should inform their healthcare team about all prescription medications, over-the-counter products, vitamins, and supplements they take to help reduce the risk of treatment complications and drug interactions.

 

Access to Multiple Medications

Support Beyond Columvi

Many times, patients taking a brand-name medication such as Columvi may require other medications.

Prescription Hope may be able to help you access all of your brand-name medications at the same low service fee of $70.00 per month, per medication.

No matter how many medications you qualify for with Prescription Hope, we can help.

Why Choose Prescription Hope for Columvi Assistance

Patient-Focused Medication Support

For 20 years, Prescription Hope has helped patients across the nation access their medications at low and affordable rates.

Simplified Access to Specialty Medications

Our patients enjoy peace of mind, knowing that not only do we advocate on their behalf throughout the application process, but that we continue to serve them for as long as they are a patient with us. We handle refill scheduling, yearly renewals, document updates, and much more.

Clear Monthly Pricing

Our service rate is a simple $70.00 per month, per medication. That means no hassles, hidden fees, or medication costs.

And if we cannot help you save on your medication, then you pay nothing!

Nationwide Network Access

Prescription Hope works with a network that spans the entire nation and includes pharmaceutical manufacturers, healthcare providers, and industry professionals.

If you’re looking for Columvi assistance and want to apply for the Columvi Patient Assistance Program, then enroll with Prescription Hope today and find out how we can help you save on your monthly medication costs.